To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Stanford V is a chemotherapy regimen designed for Hodgkin's lymphoma that consists of the following:
Additional recommended knowledge
It is a newer method than MOPP or ABVD, the two previous most common treatments for Hodgkin's lymphoma.
The chemotherapy part of Stanford V treatment can last anywhere from 8 to 12 weeks, depending on the staging of the disease. In many cases, this is followed by radiation therapy for anywhere from 2 to 6 weeks to the affected areas of the body.
It is believed that Stanford V is at least as effective as other methods of treatment. Stanford V is a more rigorously administered form of chemotherapy, with treatments roughly twice as fast as those of other Hodgkin's lymphoma treatments; however, this is tempered by the need for radiation therapy in most cases which is not typically required under ABVD.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Stanford_V". A list of authors is available in Wikipedia.|